Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in CDXS — Codexis, Inc.

CIK 1107261 HOUSTON, TX
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$284,552
+$79,322 QoQ
Shares Held
125,908
0.0% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#45
of 148 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. CDXS ranks #69 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLUE
Monte Rosa Therapeutics, Inc.
 552,566 $13,372,097
2 INVA
Innoviva, Inc.
 350,253 $7,954,245
3 PBYI
Puma Biotechnology, Inc.
 791,616 $6,420,005
4 RIGL
Rigel Pharmaceuticals Inc
 124,184 $4,858,078
5 EXEL
Exelixis, Inc.
 66,100 $3,596,501
6 CRMD
CorMedix Inc.
 434,132 $3,407,936
7 KROS
Keros Therapeutics, Inc.
 265,017 $2,835,681
8 PTCT
Ptc Therapeutics, Inc.
 22,000 $1,794,540

All Filings in CDXS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $284,552 125,908
2026-03-31 $205,230 125,908
2025-12-31 $245,980 150,908
2025-09-30 $246,215 100,908
2025-06-30 $246,215 100,908
2025-03-31 $254,495 94,608
2024-12-31 $1,125,758 236,008
2024-09-30 $745,360 242,000
2024-06-30 $750,200 242,000
2024-03-31 $844,580 242,000
2023-12-31 $600,850 197,000
2023-09-30 $434,700 230,000
2023-06-30 $371,280 132,600